Shay Shemesh - 16 Nov 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Dev. & Ops. Officer
Signature
/s/ Shay Shemesh
Issuer symbol
NVCT
Transactions as of
16 Nov 2022
Net transactions value
+$2,145
Form type
4
Filing time
18 Nov 2022, 07:30:23 UTC
Previous filing
27 Sep 2022
Next filing
22 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,065 +150 +0.01% $7.10 1,245,215 16 Nov 2022 Direct F1
transaction NVCT Common Stock Purchase $1,080 +150 +0.01% $7.20 1,245,365 17 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 48,399 shares of restricted stock and 60,000 restricted stock units.